CancerIQ

Chicago, IL · Founded 2013 · Privately Held (backing)

Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer. CancerIQ is based in Chicago, IL and was founded in 2013. Its last reported valuation was $50 million in Mar 2022. It has raised $30.8 million.

Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$30.8M
Last round
—

Who backs CancerIQ?

26 investors
InvestorType
Matter (Consulting Services (B2B))Other
Lightbank (Venture Capital)Venture capital
MSD Global Health Innovation FundVenture capital
HealthX VenturesVenture capital
Impact EngineOther
McKesson VenturesOther
OSF VenturesOther
Skydeck CapitalFamily office
1776.—
1871—
+ 16 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CancerIQ investors

Free account
More of CancerIQ with a free account
  • ·The complete investor list: 26 names
  • ·Watch CancerIQ: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 26 firms already write checks for companies like CancerIQ. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View